{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:08:21Z","timestamp":1782122901518,"version":"3.54.5"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["307794\/2019\\u20139"],"award-info":[{"award-number":["307794\/2019\\u20139"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["305343\/2019\\u20130"],"award-info":[{"award-number":["305343\/2019\\u20130"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Foundation for Research Support of Rio Grande do Sul State","doi-asserted-by":"publisher","award":["23\/2551\\u20130000125\\u20130"],"award-info":[{"award-number":["23\/2551\\u20130000125\\u20130"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013383","name":"Instituto Nacional de Ci\u00eancia e Tecnologia: F\u00edsica Nuclear e Aplica\u00e7\u00f5es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50928\\u20132"],"award-info":[{"award-number":["2014\/50928\\u20132"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["465687\/2014\\u20138"],"award-info":[{"award-number":["465687\/2014\\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.colsurfb.2025.115175","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:01:32Z","timestamp":1759539692000},"page":"115175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Surface-modified organic nanoparticles for lung cancer targeted therapy"],"prefix":"10.1016","volume":"257","author":[{"given":"Samanta da Silva","family":"G\u00fcndel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline de Cristo Soares","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danieli Rosane","family":"Dallemole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Raffin","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115175_bib1","unstructured":"International Agency for Research on Cancer (IARC). 2024. Incidence and Mortality, Both sexes, in 2022. Available in: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/15-trachea-bronchus-and-lung-fact-sheet.pdf."},{"key":"10.1016\/j.colsurfb.2025.115175_bib2","article-title":"Progress and prospects of early detection in lung cancer","volume":"7","author":"Knight","year":"2017","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib3","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1080\/10717544.2021.1981492","article-title":"Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices","volume":"28","author":"Yu","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115175_bib4","unstructured":"American Cancer Society. (2020) Chemotherapy for Non-Small Cell Lung Cancer. Available in: https:\/\/www.cancer.org\/cancer\/lung-cancer\/treating-non-small-cell\/chemotherapy.html.."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib5","first-page":"189","article-title":"Lung cancer: biology and treatment options","volume":"1856","author":"Lemjabbar-Alaoui","year":"2015","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2012.03.002","article-title":"Cancer chemotherapy: a critical analysis of its 60 years of history","volume":"84","author":"Galmarini","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115175_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"JM. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.colsurfb.2025.115175_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med"},{"key":"10.1016\/j.colsurfb.2025.115175_bib10","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.2147\/IJN.S231477","article-title":"Biomedical applications of multifunctional polymeric nanocarriers: a review of current literature","volume":"15","author":"Karabasz","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115175_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib13","series-title":"Drug Delivery. Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-00477-3_1","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","author":"Torchilin","year":"2010"},{"key":"10.1016\/j.colsurfb.2025.115175_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16447-6","article-title":"Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell lines","volume":"7","author":"Lunova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.115175_bib15","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.colsurfb.2025.115175_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","article-title":"Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review","volume":"351","author":"Elkomy","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib17","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, poly(ethylene) glycol and its alternatives","volume":"180","author":"Shi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2025.115175_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115175_bib19","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115175_bib20","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/pharmaceutics15092233","article-title":"Recent advances in targeted drug delivery strategy for enhancing oncotherapy","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115175_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115175_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.colsurfb.2025.115175_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117535","article-title":"Mechanistic study of cancer drug delivery: current techniques, limitations, and future prospects","volume":"290","author":"Imtiaz","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.115175_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Peppas","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","article-title":"Functionalizing nanoparticles with cancer targeting antibodies: a comparison of strategies","volume":"320","author":"Marques","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587012","article-title":"Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization","volume":"7","author":"Sanit\u00e0","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115175_bib31","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.3390\/molecules18089531","article-title":"Alkyne-azide \u201cclick\u201d chemistry in designing nanocarriers for applications in biology","volume":"18","author":"Avti","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115175_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/polym8040156","article-title":"Design and utility of metal\/metal oxide nanoparticles mediated by thioether end-functionalized polymeric ligands","volume":"8","author":"Razzaque","year":"2016","journal-title":"Polymers"},{"issue":"28","key":"10.1016\/j.colsurfb.2025.115175_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2007.03.075","article-title":"Reaction of an introverted carboxylic acid with carbodiimide","volume":"63","author":"Iwasawa","year":"2007","journal-title":"Tetrahedron"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115175_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1399-3011.1981.tb03007.x","article-title":"Enhancement of peptide coupling reactions by 4-dimethylaminopyridine","volume":"18","author":"Wang","year":"1981","journal-title":"Int. J. Pept. Protein Res"},{"issue":"17","key":"10.1016\/j.colsurfb.2025.115175_bib35","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1021\/bi00741a019","article-title":"Methyl 4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to the escherichia coli 30S ribosome","volume":"12","author":"Traut","year":"1973","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115175_bib36","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.bioconjchem.5b00399","article-title":"Field guide to challenges and opportunities in antibody-drug conjugates for chemists","volume":"26","author":"Gordon","year":"2015","journal-title":"Bioconjug Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1039\/B714144K","article-title":"The surface functionalisation of gold nanoparticles with metal complexes","author":"Wilton-Ely","year":"2008","journal-title":"Dalton Trans."},{"key":"10.1016\/j.colsurfb.2025.115175_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11095-020-02804-0","article-title":"Chitosan-coated lipid-core nanocapsules functionalized with gold-III and bevacizumab induced in vitro cytotoxicity against C6 cell line and in vivo potent antiangiogenic activity","volume":"37","author":"Alves","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.colsurfb.2025.115175_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11095-014-1508-y","article-title":"Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type I","volume":"32","author":"Mayer","year":"2015","journal-title":"Pharm. Res"},{"key":"10.1016\/j.colsurfb.2025.115175_bib40","article-title":"Triclosan and \u237a-bisabolol\u2013loaded nanocapsule functionalized with ascorbic acid as a dry powder formulation against A549 lung cancer cells","volume":"74","author":"De Marchi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib41","article-title":"AR. Folic acid-doxorubicin polymeric nanocapsules: a promising formulation for the treatment of triple-negative breast cancer","volume":"165","author":"Couto","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/pharmaceutics13060862","article-title":"Nanoformulation shows cytotoxicity against glioblastoma cell lines and antiangiogenic activity in chicken chorioallantoic membrane","volume":"13","author":"Dallemole","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115175_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11095-016-2074-2","article-title":"Bromelain-functionalized multiple-wall lipid-core nanocapsules: formulation, chemical structure and antiproliferative effect against human breast cancer cells (MCF-7)","volume":"34","author":"Oliveira","year":"2017","journal-title":"Pharm. Res"},{"issue":"10","key":"10.1016\/j.colsurfb.2025.115175_bib44","first-page":"983","article-title":"Nanoc\u00e1psulas de n\u00facleo lip\u00eddico: Prepara\u00e7\u00e3o, caracteriza\u00e7\u00e3o e aplica\u00e7\u00f5es biol\u00f3gicas","volume":"46","author":"Dallemole","year":"2023","journal-title":"Quim. Nova"},{"key":"10.1016\/j.colsurfb.2025.115175_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1134\/S1070328406120013","article-title":"Coordination chemistry of nanoparticles","volume":"32","author":"Gubin","year":"2006","journal-title":"Russ. J. Coord. Chem."},{"key":"10.1016\/j.colsurfb.2025.115175_bib46","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/acs.molpharmaceut.6b00187","article-title":"Combination approach of YSA peptide anchored docetaxel stealth liposomes with oral antifibrotic agent for the treatment of lung cancer","volume":"13","author":"Patel","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib47","article-title":"A review on synthesis, characterizations, and applications of schiff base functionalized nanoparticles","volume":"6","author":"Khan","year":"2023","journal-title":"Results Chem."},{"key":"10.1016\/j.colsurfb.2025.115175_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1208\/s12249-020-01742-9","article-title":"Development and characterization of biocompatible mannose functionalized mesospheres: an effective chemotherapeutic approach for lung cancer targeting","volume":"21","author":"Gautam","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib49","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3390\/ijms14022303","article-title":"Molecular motions in functional self-assembled nanostructures","volume":"14","author":"Dhotel","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115175_bib50","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/nano12030354","article-title":"Recent advances in the surface functionalization of PLGA-based nanomedicines","volume":"12","author":"El-Hammadi","year":"2022","journal-title":"Nanomaterials"},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115175_bib51","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/ijms21072536","article-title":"Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy","volume":"21","author":"Gessner","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib52","series-title":"Hydration Processes in Biology","first-page":"115","article-title":"The structural basis of the hydrophobic interaction","author":"Finney","year":"1999"},{"key":"10.1016\/j.colsurfb.2025.115175_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/151683","article-title":"Amphiphiles self-assembly: basic concepts and future perspectives of supramolecular approaches","volume":"2015","author":"Lombardo","year":"2015","journal-title":"Adv. Cond. Matter Phys."},{"key":"10.1016\/j.colsurfb.2025.115175_bib54","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1039\/c3nr02176a","article-title":"Supramolecular self-assemblies as functional nanomaterials","volume":"5","author":"Busseron","year":"2013","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","article-title":"Nanoprecipitation process: from encapsulation to drug delivery","volume":"532","author":"Rivas","year":"2017","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115175_bib57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinchem\/37.5.625","article-title":"The biotin-(strept)avidin system: principles and applications in biotechnology","volume":"37","author":"Diamandis","year":"1991","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/nano15040285","article-title":"Magnetic nanoparticles and drug delivery systems for anti-cancer applications: a review","volume":"15","author":"Graham","year":"2025","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.surfrep.2017.02.001","article-title":"Nanoparticle decoration with surfactants: molecular interactions, assembly, and applications","volume":"72","author":"Heinz","year":"2017","journal-title":"Surf. Sci. Rep."},{"issue":"182","key":"10.1016\/j.colsurfb.2025.115175_bib60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.24976\/Discov.Med.202436182.42","article-title":"pH-dependent non-covalent release of chemotherapy from carriers","volume":"36","author":"Leng","year":"2024","journal-title":"Discov. Med"},{"issue":"13","key":"10.1016\/j.colsurfb.2025.115175_bib61","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.3390\/ijms23136902","article-title":"Non-covalent interaction on the self-healing of mechanical properties in supramolecular polymers","volume":"23","author":"Buaksuntear","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/pr9040621","article-title":"Onco-receptors targeting in lung cancer via application of surface-modified and hybrid nanoparticles: a cross-disciplinary review","volume":"9","author":"Sabir","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.colsurfb.2025.115175_bib63","article-title":"Application of nanoparticles in the treatment of lung cancer with emphasis on receptors","volume":"12","author":"Wang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib64","article-title":"Surface functionalization of lipidic core nanoparticles with albumin: a great opportunity for quinacrine in lung cancer therapy","volume":"75","author":"Sabzichi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12951-021-00977-3","article-title":"A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib66","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1021\/acs.molpharmaceut.0c00052","article-title":"Treatment of lung cancer by peptide-modified liposomal irinotecan endowed with tumor penetration and NF-\u03baB inhibitory activities","volume":"17","author":"Hu","year":"2020","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115175_bib67","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1080\/03639045.2018.1512613","article-title":"Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria","volume":"44","author":"Tian","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pupt.2019.02.001","article-title":"Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy","volume":"55","author":"Zhu","year":"2019","journal-title":"Pulm. Pharm. Ther."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115175_bib69","first-page":"1864","article-title":"Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting","volume":"46","author":"Ma","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1039\/C6BM00788K","article-title":"J. Atb0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes","volume":"5","author":"Luo","year":"2017","journal-title":"Biomater. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib71","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.18632\/oncotarget.6013","article-title":"Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines","volume":"7","author":"Perillo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2025.115175_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1348.001","article-title":"Surface-modified LPD nanoparticles for tumor targeting","volume":"1082","author":"Li","year":"2006","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2019.02.001","article-title":"Afatinib-loaded immunoliposomes functionalized with cetuximab: a novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer","volume":"560","author":"Lu","year":"2019","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.colsurfb.2018.05.008","article-title":"Hyaluronate\/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma","volume":"169","author":"Kabary","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2025.115175_bib75","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/IJN.S77837","article-title":"Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA","volume":"10","author":"Shao","year":"2015","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115175_bib76","first-page":"4107","article-title":"Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin","volume":"9","author":"Han","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115175_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109225","article-title":"Synergistic combination therapy of lung cancer: cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122846","article-title":"Surface-modified nanoparticles of docetaxel for chemotherapy of lung cancer: an intravenous to oral switch","volume":"636","author":"Rawal","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib79","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acs.molpharmaceut.7b00846","article-title":"New Folate-Grafted chitosan derivative to improve delivery of Paclitaxel-Loaded solid lipid nanoparticles for lung tumor therapy by inhalation","volume":"15","author":"Rosi\u00e8re","year":"2018","journal-title":"Mol. Pharm."},{"issue":"61","key":"10.1016\/j.colsurfb.2025.115175_bib80","doi-asserted-by":"crossref","first-page":"49122","DOI":"10.1039\/C5RA03316K","article-title":"Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles","author":"Pooja","year":"2015","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3892\/ijmm.2014.1770","article-title":"Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy","volume":"34","author":"Han","year":"2014","journal-title":"Int J. Mol. Med"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib82","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acsabm.3c01145","article-title":"Anticancer and antibacterial properties of curcumin-loaded mannosylated solid lipid nanoparticles for the treatment of lung diseases","volume":"7","author":"Chae","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.colsurfb.2025.115175_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12951-017-0316-z","article-title":"Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells","volume":"15","author":"Zhou","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib84","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ijbiomac.2021.04.054","article-title":"Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse\/human chimeric antibody as a promising targeting strategy of lung tumors","volume":"182","author":"Castro","year":"2021","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopha.2015.01.008","article-title":"Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer","volume":"70","author":"Wang","year":"2015","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib86","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-022-08759-z","article-title":"Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers","volume":"12","author":"Shahrad","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib87","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/10717544.2022.2036871","article-title":"Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115175_bib88","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1007\/s10853-023-08490-8","article-title":"S. Surface-functionalized luteolin-loaded nanocarriers successfully delayed lung cancer progress in rats","volume":"58","author":"Sen","year":"2023","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121038","article-title":"Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles \u2013 efficacy in Non-Small cell lung cancer (NSCLC) treatment","volume":"608","author":"Parvathaneni","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2021.07.035","article-title":"p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer","volume":"337","author":"Garizo","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib91","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/cancers11040491","article-title":"Improving payload capacity and anti-tumor efficacy of mesenchymal stem cells using TAT peptide functionalized polymeric nanoparticles","volume":"11","author":"Moku","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115175_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phymed.2018.09.013","article-title":"A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: enhanced apoptosis and metalloproteinase-9 down-regulation","volume":"53","author":"Parashar","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.colsurfb.2025.115175_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2016.12.024","article-title":"Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer","volume":"259","author":"Wu","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15012-5","article-title":"Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy","volume":"7","author":"Babu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.115175_bib95","first-page":"775","article-title":"Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake","volume":"10","author":"Lamichhane","year":"2015","journal-title":"Int J. Nanomed."},{"issue":"24","key":"10.1016\/j.colsurfb.2025.115175_bib96","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/smll.201301417","article-title":"Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model","volume":"9","author":"Karra","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2025.115175_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701135","article-title":"Selective cell penetrating peptide-functionalized polymersomes mediate efficient and targeted delivery of methotrexate disodium to human lung cancer in vivo","volume":"7","author":"Yang","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2025.115175_bib98","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.actbio.2018.01.015","article-title":"Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo","volume":"70","author":"Yang","year":"2018","journal-title":"Acta Biomate"},{"key":"10.1016\/j.colsurfb.2025.115175_bib99","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.1021\/acs.chemmater.7b02953","article-title":"Bioresponsive chimaeric nanopolymersomes enable targeted and efficacious protein therapy for human lung cancers in vivo","volume":"29","author":"Yang","year":"2017","journal-title":"Chem. Mater."},{"key":"10.1016\/j.colsurfb.2025.115175_bib100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-021-02170-z","article-title":"Sialic acid conjugated chitosan nanoparticles: modulation to target tumour cells and therapeutic opportunities","volume":"23","author":"Rana","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2025.115175_bib101","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejpb.2016.10.014","article-title":"Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells","volume":"109","author":"Huang","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib102","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.biomaterials.2009.03.010","article-title":"The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation","volume":"30","author":"Tseng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115175_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12951-014-0037-5","article-title":"Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis","volume":"12","author":"Long","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijbiomac.2022.02.095","article-title":"Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro","volume":"206","author":"Essa","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib105","article-title":"Avidin-Biotin functionalized self-assembled protein nanoparticles as EGFR targeted therapeutics for the treatment of lung cancer: characterization and cell viability","author":"Panjwani","year":"2022","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib106","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jconrel.2018.07.014","article-title":"Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo\/herbal therapy","volume":"285","author":"Elgohary","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib107","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.colsurfb.2016.05.050","article-title":"Impact of surface modification in BSA nanoparticles for uptake in cancer cells","volume":"145","author":"Choi","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2025.115175_bib108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2014.11.008","article-title":"Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer","volume":"197","author":"Choi","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib109","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acsbiomaterials.9b01639","article-title":"Inhalable lactoferrin\/chondroitin-functionalized monoolein nanocomposites for localized lung cancer targeting","volume":"6","author":"Abdelaziz","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"16","key":"10.1016\/j.colsurfb.2025.115175_bib110","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2217\/nnm-2018-0039","article-title":"Inhalable lactoferrin\u2013chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma","volume":"13","author":"Abd Elwakil","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2025.115175_bib111","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1021\/acs.molpharmaceut.7b00900","article-title":"Evaluation of MUC1-aptamer functionalized hybrid nanoparticles for targeted delivery of miRNA-29b to non-small cell lung cancer","volume":"15","author":"Perepelyuk","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib112","first-page":"2087","article-title":"Lung carcinoma therapy using epidermal growth factor receptor-targeted lipid polymeric nanoparticles co-loaded with cisplatin and doxorubicin","volume":"42","author":"Nan","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.colsurfb.2025.115175_bib113","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/DDDT.S296253","article-title":"Transferrin-decorated protein-lipid hybrid nanoparticle efficiently delivers cisplatin and docetaxel for targeted lung cancer treatment","volume":"15","author":"Mao","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.colsurfb.2025.115175_bib114","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ph13100273","article-title":"Epidermal growth factor receptor (EGFR)-mutated Non-Small-Cell lung cancer (NSCLC)","volume":"13","author":"O\u2019Leary","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.colsurfb.2025.115175_bib115","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1016\/j.biomaterials.2013.07.100","article-title":"Epidermal growth factor receptor targeting in cancer: a review of trends and strategies","volume":"34","author":"Yewale","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115175_bib116","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/nano15030158","article-title":"Surface functionalization of nanocarriers with anti-egfr ligands for cancer active targeting","volume":"15","author":"Spada","year":"2025","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib117","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/pharmaceutics15061648","article-title":"Targeting peptides: the new generation of targeted drug delivery systems","volume":"15","author":"Todaro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115175_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120795","article-title":"Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: biological strategy, design and quality control","volume":"605","author":"Nguyen","year":"2021","journal-title":"Int J. Pharm."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib119","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.colsurfb.2025.115175_bib120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115175_bib121","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1039\/C9NR08784B","article-title":"Impact of plasma concentration of transferrin on targeting capacity of nanoparticles","volume":"12","author":"Sepand","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.colsurfb.2025.115175_bib122","article-title":"Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotech"},{"key":"10.1016\/j.colsurfb.2025.115175_bib124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pharmaceutics14010014","article-title":"Active targeted nanoformulations via folate receptors: state of the art and future perspectives","volume":"14","author":"Mart\u00edn-Sabroso","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115175_bib125","first-page":"4989","article-title":"A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer","volume":"9","author":"Shi","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2025.115175_bib126","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/C7SC04004K","article-title":"Advances in targeting the folate receptor in the treatment\/imaging of cancers","volume":"9","author":"Fern\u00e1ndez","year":"2018","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pharmaceutics14010014","article-title":"Active targeted nanoformulations via folate receptors: state of the art and future perspectives","volume":"14","author":"Mart\u00edn-Sabroso","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115175_bib128","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1039\/D3SC05539F","article-title":"K. Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis","volume":"15","author":"Ahmadi","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6667735","article-title":"Proteolytic processing of CD44 and its implications in cancer","volume":"2021","author":"Medrano-Gonz\u00e1lez","year":"2021","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.colsurfb.2025.115175_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108374","article-title":"CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations","volume":"787","author":"Gomari","year":"2021","journal-title":"Mutat. Res."},{"key":"10.1016\/j.colsurfb.2025.115175_bib131","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/polym10101133","article-title":"Hyaluronic acid-based nanomaterials for cancer therapy","volume":"10","author":"Kim","year":"2018","journal-title":"Polymers"},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115175_bib132","first-page":"1967","article-title":"New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy","volume":"46","author":"Safdar","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115175_bib133","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0046-8177(97)90154-4","article-title":"Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas","volume":"28","author":"Tran","year":"1997","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115175_bib134","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1096-9098(199811)69:3<128::AID-JSO3>3.0.CO;2-M","article-title":"High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers","volume":"69","author":"Kondo","year":"1998","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/CBM-140424","article-title":"Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer","volume":"14","author":"Roudi","year":"2014","journal-title":"Cancer Biomark."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115175_bib136","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tcb.2019.03.003","article-title":"Intratumoral heterogeneity: more than just mutations","volume":"29","author":"Hinohara","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.588066","article-title":"Integrin-ligand interactions in inflammation, cancer, and metabolic disease: insights into the multifaceted roles of an emerging ligand irisin","volume":"8","author":"Park","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib138","doi-asserted-by":"crossref","first-page":"e15746","DOI":"10.1371\/journal.pone.0015746","article-title":"Acidic extracellular ph promotes activation of integrin \u03b1v\u03b23","volume":"6","author":"Paradise","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115175_bib139","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1091\/mbc.e04-12-1082","article-title":"Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression","volume":"16","author":"Cowden Dahl","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"13","key":"10.1016\/j.colsurfb.2025.115175_bib140","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1535370220934038","article-title":"Hypoxic tumor microenvironment: implications for cancer therapy","volume":"245","author":"Roy","year":"2020","journal-title":"Exp. Biol. Med"},{"key":"10.1016\/j.colsurfb.2025.115175_bib141","doi-asserted-by":"crossref","first-page":"37252","DOI":"10.18632\/oncotarget.26442","article-title":"Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy","volume":"9","author":"Tripathi","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115175_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.822","article-title":"The role of cell-penetrating peptides in potential anti-cancer therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.colsurfb.2025.115175_bib143","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijms26010002","article-title":"Cancer-targeting applications of cell-penetrating peptides","volume":"26","author":"Moreno-Vargas","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib144","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1039\/c1sm05398a","article-title":"Molecular understanding of receptor-mediated membrane responses to ligand-coated nanoparticles","volume":"7","author":"Yue","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.colsurfb.2025.115175_bib145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2025.01.060","article-title":"Receptor-ligand interactions for optimized endocytosis in targeted therapies","volume":"380","author":"Sung","year":"2025","journal-title":"J. Control Release"},{"issue":"23","key":"10.1016\/j.colsurfb.2025.115175_bib146","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.biomaterials.2012.04.055","article-title":"Role of physicochemical properties of coating ligands in receptor-mediated endocytosis of nanoparticles","volume":"33","author":"Ding","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115175_bib147","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170063","article-title":"Effects of ligand distribution on receptor-diffusion-mediated cellular uptake of nanoparticles","author":"Li","year":"2017","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib148","doi-asserted-by":"crossref","DOI":"10.1063\/1.3293303","article-title":"Effects of particle size and ligand density on the kinetics of receptor-mediated endocytosis of nanoparticles","volume":"96","author":"Yuan","year":"2010","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.colsurfb.2025.115175_bib149","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1039\/c2ra01168a","article-title":"Ligand density and clustering effects on endocytosis of folate modified nanoparticles","volume":"2","author":"Moradi","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2025.115175_bib150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2018.07.006","article-title":"Receptor mediated transcytosis in biological barrier: the influence of receptor character and their ligand density on the transmembrane pathway of active-targeting nanocarriers","volume":"180","author":"Song","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115175_bib151","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.3390\/ijms241713048","article-title":"Improving cancer targeting: a study on the effect of dual-ligand density on targeting of cells having differential expression of target biomarkers","volume":"24","author":"Sultana","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib152","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fphar.2018.01230","article-title":"Tumor microenvironment targeted nanotherapy","volume":"9","author":"Fernandes","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.colsurfb.2025.115175_bib153","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.colsurfb.2025.115175_bib154","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fphar.2017.00952","article-title":"Modulating the tumor microenvironment to enhance tumor nanomedicine delivery","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/nsr\/nwx062","article-title":"The acidic tumor microenvironment: a target for smart cancer nano-theranostics","volume":"5","author":"Feng","year":"2018","journal-title":"Natl. Sci. Rev."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115175_bib156","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/wnan.1389","article-title":"pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents","volume":"8","author":"Karimi","year":"2016","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.855019","article-title":"pH-responsive polymer nanomaterials for tumor therapy","volume":"12","author":"Chu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib158","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib159","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12989-017-0199-z","article-title":"Mechanistic understanding of nanoparticles\u2019 interactions with extracellular matrix: the cell and immune system","volume":"14","author":"Engin","year":"2017","journal-title":"Part Fibre Toxicol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib160","article-title":"Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment","volume":"120","author":"He","year":"2022","journal-title":"Biophys. Comput. Biol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib161","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fimmu.2017.01287","article-title":"Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors","volume":"8","author":"Xenaki","year":"2017","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115175_bib162","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","article-title":"Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance","volume":"60","author":"Thurber","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib163","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6800","article-title":"RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin\u2013RGD interactions","volume":"13","author":"Javid","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.colsurfb.2025.115175_bib165","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.2147\/IJN.S487303","article-title":"Research progress on cyclic-peptide functionalized nanoparticles for tumor-penetrating delivery","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115175_bib166","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib167","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/1568009616666151130214646","article-title":"Targeting tumors with small molecule peptides","volume":"16","author":"Cheetham","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115175_bib168","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115175_bib169","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/mp900015y","article-title":"The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic","volume":"6","author":"Davis","year":"2009","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115175_bib170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2025.115175_bib171","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-024-02133-1","article-title":"Liposomal irinotecan: a review as first-line therapy in metastatic pancreatic adenocarcinoma","volume":"85","author":"Brown","year":"2025","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115175_bib172","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1158\/1078-0432.CCR-23-3029","article-title":"A first-in-human phase 1 study of a tumor-directed RNA-interference drug against HIF2\u03b1 in patients with advanced clear cell renal cell carcinoma","volume":"30","author":"Brugarolas","year":"2024","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115175_bib173","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","article-title":"Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer","volume":"76","author":"Espelin","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.colsurfb.2025.115175_bib174","article-title":"Towards principled design of cancer nanomedicine to accelerate clinical translation","volume":"13","author":"Souri","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115175_bib175","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.colsurfb.2025.115175_bib176","unstructured":"International Agency for Research on Cancer (IARC). 2022. Estimated number of new cases from 2022 to 2050, Both sexes, age [0-85+]. Available in: https:\/\/gco.iarc.who.int\/tomorrow\/en\/dataviz\/bars?mode=cancer&group_populations=1&multiple_cancers=1&bar_mode=grouped&years=2050&cancers=39_15&types=0."},{"key":"10.1016\/j.colsurfb.2025.115175_bib177","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-020-00881-7","article-title":"Emerging therapeutic agents for advanced non-small cell lung cancer","volume":"13","author":"Chen","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib178","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-021-01121-2","article-title":"Targeted therapy in advanced non-small cell lung cancer: current advances and future trends","volume":"14","author":"Majeed","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115175_bib179","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.colsurfb.2025.115175_bib180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom10050735","article-title":"Fabio V. Nanotechnology based strategies to develop new anticancer therapies","volume":"10","author":"Magro","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.colsurfb.2025.115175_bib181","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.colsurfb.2025.115175_bib182","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.115175_bib183","unstructured":"Food and Drug Administration (FDA). 2018. Nanotechnology Regulatory Science Research Plan. Available in: https:\/\/www.fda.gov\/science-research\/nanotechnology-programs-fda\/2013-nanotechnology-regulatory-science-research-plan.."},{"key":"10.1016\/j.colsurfb.2025.115175_bib184","first-page":"225","article-title":"Nanotechnology: regulatory outlook on nanomaterials and nanomedicines in United States, Europe and India","volume":"7","author":"Malik","year":"2020","journal-title":"Appl. Clin. Res Clin. Trials Regul. Aff."},{"key":"10.1016\/j.colsurfb.2025.115175_bib185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115175_bib186","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:53:41Z","timestamp":1778558021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525006824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":186,"alternative-id":["S0927776525006824"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115175","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-modified organic nanoparticles for lung cancer targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115175"}}